Espada, Haifa A.
HRN: 24-60-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
02/27/2024
03/04/2024
PO
0.65ml
BID
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes